| Literature DB >> 24551254 |
Lionel Sacconnay1, Melissa Angleviel1, Giuseppe Marco Randazzo1, Marcos Marçal Ferreira Queiroz1, Emerson Ferreira Queiroz1, Jean-Luc Wolfender1, Pierre-Alain Carrupt1, Alessandra Nurisso1.
Abstract
BACKGROUND: The silent-information regulator 2 proteins, otherwise called sirtuins, are currently considered as emerging anti-parasitic targets.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24551254 PMCID: PMC3923677 DOI: 10.1371/journal.pntd.0002689
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Hypothetical roles of NAD+ dependent deacetylases (sirtuin family) in the T. cruzi parasite.
Figure 2Sequence alignment between TcSir2rp1 and hSIRT2.
Conserved amino acids are highlighted in yellow.
Figure 3Molecular docking results in the productive pocket of TcSIR2rp1.
(A) Superimposition of A5dPR crystal (yellow-capped sticks) and best-ranked docking poses in hSIRT2 (green-capped sticks, cyan ribbons) and TcSIR2rp1 (white-capped sticks, dark pink ribbons). (B) NAD+ best-ranked docking pose in the TcSIR2rp1 productive form (purple-capped sticks, dark pink ribbons). (C) Nicotinamide best-ranked docking pose in the TcSIR2rp1 productive form (purple -capped sticks, dark pink ribbons). (D) AGK2 best-ranked docking pose in the TcSIR2rp1 productive form (purple-capped sticks, dark pink ribbons).
Figure 4Superimposition of ten NAD+ docking poses in the TcSIR2rp1 productive (A) and non-productive (B) forms.
NAD+ molecules are represented in brown-capped sticks. Protein structures are represented as ribbons and colored in dark pink and green representing the TcSIR2rp1 productive and non-productive form, respectively. Pocket surfaces were generated with MOE (MOE 2012.10; Chemical Computing Group, Montreal, Canada) and are colored in gray.
PLP scores for the anti-trypanosomal compounds docked into TcSIR2rp1 and TcSIR2rp3 productive forms.
| Compound (Cmp) Names | TcSir2rp1 | TcSIR2rp3 | hSIRT2 | hSIRT5 | Ref. | |
| AGK2 | 71.2 | 73.3 | - |
| ||
| Thiobarbiturate 6 | 72.3 | - | 58.8 |
| ||
|
|
|
|
|
|
|
|
| 2 | 6′-O-acetyldiderroside | 59.1 | 57.1 | - | - |
|
| 3 | Ambigol A | 54.1 | 62.7 | - | - |
|
| 4 | Ambigol C | 63.5 | 74.6 | - | - |
|
|
|
|
|
|
|
|
|
| 6 | Ancistectorine A2 | 42.0 | 43.8 | - | - |
|
| 7 | Ancistrogriffine C | −2.6 | 52.8 | - | - |
|
| 8 | Ancistrogriffithine A | 16.0 | 45.5 | - | - |
|
| 9 | Angoroside C | 59.2 | 69.0 | - | - |
|
| 10 | Caaverine | 45.9 | 53.7 | - | - |
|
| 11 | Caffeic acid | 39.5 | 53.5 | - | - |
|
| 12 | Chaetoxanthone A | 36.8 | 58.9 | - | - |
|
| 13 | Chaetoxanthone B | 37.0 | 55.4 | - | - |
|
| 14 | Chaetoxanthone C | 45.8 | 47.5 | - | - |
|
| 15 | Cissampelofavone | 45.3 | 68.6 | - | - |
|
| 16 | 7-deacetyl-gedunin | 4.7 | 55.1 | - | - |
|
| 17 | Demethyl-praecanson A | 69.8 | 63.4 | - | - |
|
| 18 | 2,2-dimethyl-6-carboxyethenyl-2H-1-benzopyrane | 55.1 | 62.9 | - | - |
|
| 19 | 2,2-dimethyl-6-carboxyethenyl-8-prenyl2H-1-benzopyrane | 72.9 | 68.0 | - | - |
|
| 20 | 6,6-dimethyl-2-methoxy-6H-benzo[c]chromen-9-yl)methanol | 49.0 | 63.5 | - | - |
|
| 21 | Ent-kaurenoic acid | 40.3 | 54.0 | - | - |
|
| 22 | Ent-naringeninyl-(I-3α,II-8)-4′-O-methylnaringenin | 25.8 | 30.2 | - | - |
|
| 23 | Gallocatechin gallate | 65.8 | 79.0 | - | - |
|
| 24 | γ-fagarine | 35.6 | 54.6 | - | - |
|
| 25 | Garciniaxanthone B | 43.7 | 45.8 | - | - |
|
| 26 | Geranylgeraniol | 67.6 | 76.4 | - | - |
|
| 27 | Garcilivin A | 25.9 | 37.3 | - | - |
|
| 28 | Haemanthamine | 44.6 | 58.6 | - | - |
|
| 29 | Helenalin | 40.6 | 49.2 | - | - |
|
| 30 | Hydroxyanthecotulide | 58.3 | 66.2 | - | - |
|
| 31 | 3-hydroxydaidzein | 52.7 | 58.7 | - | - |
|
| 32 | Rel-(7R,8R)-8-[(E)-3-hydroxy-3-methyl-1-butenyl]-4,8-dimethoxy-5,6,7,8-tetrahydrofuro[2,3b]quinoline-7-yl acetate | 65.0 | 55.8 | - | - |
|
|
|
|
|
|
|
|
|
| 34 | Ivalin | 45.7 | 55.5 | - | - |
|
| 35 | Komarovinone A | 57.8 | 42.7 | - | - |
|
| 36 | Luteolin | 61.7 | 66.9 | - | - |
|
| 37 | Isosakuranetin | 36.8 | 53.1 | - | - |
|
| 38 | Methylpluviatolide | 56.8 | 84.4 | - | - |
|
| 39 | 4′-O-demethylancistrocladinium A | 36.9 | 56.3 | - | - |
|
| 40 | Parthenolide | 43.1 | 47.0 | - | - |
|
| 41 | 4′-O-demethylknipholone-4′-O-β-d-glucopyranoside | 25.8 | 53.1 | - | - |
|
| 42 | Piperine | 65.6 | 68.3 | - | - |
|
| 43 | 3-prenyl-4-hydroxycinnamic acid | 55.2 | 67.4 | - | - |
|
| 44 | 3,5-piprenyl-4-hydroxycinnamic acid | 69.1 | 70.6 | - | - |
|
| 45 | Sarachine | 36.0 | 60.7 | - | - |
|
| 46 | Sophoraflavone G | 54.7 | 85.0 | - | - |
|
| 47 | Tiliroside | 48.9 | 95.3 | - | - |
|
| 48 | Usnic acid (R) | 38.6 | 53.2 | - | - |
|
| 49 | Usnic acid (S) | 36.7 | 65.6 | - | - |
|
|
|
|
|
|
|
|
|
The compounds selected from the virtual screening for structural inspections are reported in bold.
Figure 5Molecular docking results from the virtual screening of the productive conformational state of TcSIR2rp1.
(A) Anacardic acid best-ranked docking pose in the TcSIR2rp1 productive form. (B) Aculeatin D best-ranked docking pose in the TcSIR2rp1 productive form. (C) 16-acetoxy-11-hydroxyoctadeca-17-ene-12,14-diynylethanoate best-ranked docking pose in the TcSIR2rp1 productive form. (D) Vismione D best-ranked docking pose in the TcSIR2rp1 productive form. Protein structures are represented as dark pink ribbons. Amino acids participating in protein-ligand interactions are indicated bylight gray sticks. Ligands are represented in capped sticks and are colored in orange. GRID surface are also reported in the active site pockets and are colored as yellow, blue and red to highlight the hydrophobic, electron-donor and electron-acceptor properties, respectively.